Sastasundar Ventures Ltd

Sastasundar Ven. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sastasundar Ventures Ltd

₹ 292 0.53%
21 Nov - close price
sastasundarventures.com BSE: 533259 NSE: SASTASUNDR
About

Sastasundar Ventures Limited is a Core Investment Company (CIC) focusing on the business of digital network of healthcare and portfolio management services. The Company aims to provide healthcare services at a reasonable cost with its innovative information and knowledge based web portal.[1]

Key Points

Leadership
Sastasundar group is #1 pharma distributor in West Bengal.[1]

Website BSE NSE
  • Market Cap ₹ 930 Cr.
  • Current Price ₹ 292
  • High / Low ₹ 500 / 276
  • Stock P/E 13.2
  • Book Value ₹ 216
  • Dividend Yield 0.00 %
  • ROCE -2.95 %
  • ROE 0.77 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company's median sales growth is 42.0% of last 10 years

Cons

  • Company has a low return on equity of -4.74% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Finance Industry: Finance & Investments

Part of BSE Allcap BSE Healthcare BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
159 143 157 192 254 281 313 336 358 374 307 270 274
169 156 182 208 261 291 324 327 355 371 317 273 278
Operating Profit -10 -13 -25 -16 -6 -10 -11 9 3 3 -11 -2 -5
OPM % -6% -9% -16% -9% -2% -4% -4% 3% 1% 1% -3% -1% -2%
4 1,172 -7 5 -2 4 9 12 10 20 18 29 -167
Interest 1 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 2 2 3 2 2 2 3 2 1
Profit before tax -8 1,157 -34 -12 -11 -9 -6 19 11 21 5 25 -174
Tax % 13% 12% -24% -32% -273% -70% 288% -29% -23% 4% -583% -103% -13%
-9 1,024 -26 -22 -3 -26 -48 -0 -12 -3 22 41 -155
EPS in Rs -1.43 232.31 -6.07 -5.56 -0.39 -6.00 -10.75 0.41 -2.55 -0.24 5.17 9.79 -34.39
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
47 30 52 89 135 162 222 388 551 1,798 1,060 1,432 1,225
32 35 62 116 155 175 255 440 561 684 1,168 1,456 1,239
Operating Profit 15 -4 -10 -28 -20 -13 -33 -52 -10 1,114 -107 -24 -14
OPM % 33% -15% -19% -31% -15% -8% -15% -13% -2% 62% -10% -2% -1%
0 0 2 -0 2 7 0 1 1 3 -5 4 -100
Interest 1 1 1 2 3 1 3 1 3 3 2 1 1
Depreciation 2 2 6 7 7 6 6 5 4 4 8 9 8
Profit before tax 13 -7 -15 -37 -28 -12 -42 -58 -16 1,109 -122 -30 -123
Tax % 31% -5% -0% -1% 2% 19% 3% -9% 4% 22% -19% -119%
8 -6 -15 -37 -29 -15 -43 -52 -17 865 -99 6 -95
EPS in Rs 2.58 -2.03 -4.68 -11.51 -9.00 -3.73 -11.81 -12.19 -3.27 197.05 -22.70 2.79 -19.67
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 47%
5 Years: 45%
3 Years: 38%
TTM: -5%
Compounded Profit Growth
10 Years: 11%
5 Years: 17%
3 Years: 37%
TTM: 214%
Stock Price CAGR
10 Years: 14%
5 Years: 29%
3 Years: -17%
1 Year: -37%
Return on Equity
10 Years: -8%
5 Years: -6%
3 Years: -5%
Last Year: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 32 32 32 32 32 32 32 32 32 32 32 32 32
Reserves 245 238 223 186 163 144 106 173 163 790 717 726 657
3 0 5 19 21 12 2 8 12 2 9 4 1
35 39 22 20 35 48 91 103 85 454 446 388 315
Total Liabilities 315 309 281 256 251 235 230 316 293 1,278 1,204 1,149 1,005
94 117 137 126 125 117 116 114 110 93 107 110 104
CWIP 8 0 3 0 0 1 1 0 0 0 1 0 1
Investments 64 41 22 10 17 46 36 56 43 666 513 676 466
148 151 119 120 110 71 77 146 139 518 583 363 434
Total Assets 315 309 281 256 251 235 230 316 293 1,278 1,204 1,149 1,005

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
38 36 -12 -12 -2 -49 -30 -69 -31 -207 -112 38
-8 -42 7 -1 4 15 -2 -22 21 220 133 -34
-19 -3 4 13 5 33 26 103 4 -11 -2 -2
Net Cash Flow 11 -10 -1 -0 7 -2 -6 11 -5 1 19 2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 59 169 87 34 52 9 13 14 9 4 12 11
Inventory Days 337 91 80 73 59 77 57 71 69 34
Days Payable 165 38 69 24 26 50 29 21 22 13
Cash Conversion Cycle 59 169 259 87 62 58 46 41 38 55 59 33
Working Capital Days 417 443 377 247 99 89 61 54 44 46 93 58
ROCE % 5% -2% -6% -14% -12% -8% -19% -25% -6% -7% -11% -3%

Shareholding Pattern

Numbers in percentages

6 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
73.72% 73.72% 73.92% 73.92% 73.92% 73.92% 73.92% 73.92% 73.92% 73.92% 73.92% 73.92%
0.20% 0.52% 0.47% 0.40% 0.22% 0.32% 0.31% 0.32% 0.49% 0.56% 0.61% 0.99%
0.02% 0.05% 0.09% 0.09% 0.09% 0.09% 0.17% 0.17% 0.86% 0.96% 1.35% 1.98%
26.06% 25.71% 25.52% 25.61% 25.78% 25.68% 25.60% 25.60% 24.73% 24.57% 24.12% 23.11%
No. of Shareholders 14,27615,17415,24715,55415,16615,08814,75214,63314,05314,54414,49315,360

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls